10 Elms LLP Novartis Ag Transaction History
10 Elms LLP
- $99.5 Billion
- Q1 2025
A detailed history of 10 Elms LLP transactions in Novartis Ag stock. As of the latest transaction made, 10 Elms LLP holds 700 shares of NVS stock, worth $81,039. This represents 0.08% of its overall portfolio holdings.
Number of Shares
700
Previous 700
-0.0%
Holding current value
$81,039
Previous $68.1 Million
14.56%
% of portfolio
0.08%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,523Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...